MAP2K1 and neoplasm: Genetic analysis of the tumor was performed using a diagnostic biochip for the detection of somatic mutations in the BRAF, NRAS, KIT, GNAQ, GNA11, MAP2K1, and MAP2K2 genes, Sanger sequencing for searching germinal mutations in the CDKN2A gene.